Product Summary
DrugCard is an AI-driven solution for screening local scientific literature tailored to the pharmaceutical industry. It automates continuous monitoring of region-specific publications to support pharmacovigilance and product safety programs, helping organizations keep pace with relevant local research and regulatory expectations.
Primary Advantages
- Cost-efficient implementation that avoids large upfront investments, making it accessible to organizations of different sizes.
- Designed to scale across regions and operations, so it can grow with a company's geographic footprint.
- Built-in audit trails and transparent logging to support verification of screening completeness and methodological consistency.
Capabilities and Coverage
DrugCard processes content in 100+ languages and indexes medical literature from more than 35 countries, enabling broad local-market visibility. It combines automated screening with configurable review workflows to deliver timely, relevant hits from regional journals and other local sources.
Typical Users
- Freelancers and independent consultants conducting literature searches and case assessment.
- Marketing Authorization Holders (MAHs) who need continuous local-literature surveillance for products under their responsibility.
- Contract Research Organizations (CROs) managing screening tasks for sponsors and regulatory submissions.
Compliance and Traceability
The platform emphasizes reproducibility and traceability: every screening run is logged, decisions and filters are recorded, and reporting supports regulatory review. These features assist teams in demonstrating that literature surveillance was comprehensive and methodical.
Deployment Options and Cost Considerations
DrugCard is offered as a scalable service model that minimizes capital expenditure. Organizations can deploy it without major infrastructure outlay, selecting capacity and coverage based on current needs and expanding as projects grow.
Other Options to Consider
Cappella (paid) is an alternative solution worth evaluating for organizations that want a different vendor offering or feature set.
Technical
- Web App
- Full